United States · FDA National Drug Code directory

D-136

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 58264-0145_2b9efed7-5d89-16bd-e063-6394a90ac14f
Product NDC: 58264-0145
Form: SOLUTION
Composition / generic term: somatropin, long-(arg3)insulin-like growth factor-i, arsenic trioxide, saw palmetto, platinum, oyster shell calcium carbonate, crude, bos taurus adrenal cortex, bos taurus pituitary gland, posterior, thyroid, unspecified, and bos taurus hypothalamus
Labeler: DNA Labs, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19900101
Source listing expiry: 20261231

Source-listed ingredients

SOMATROPIN — 12 [hp_X]/mL
LONG-(ARG3)INSULIN-LIKE GROWTH FACTOR-I — 12 [hp_X]/mL
ARSENIC TRIOXIDE — 6 [hp_X]/mL
SAW PALMETTO — 12 [hp_X]/mL
PLATINUM — 30 [hp_X]/mL
OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
BOS TAURUS ADRENAL CORTEX — 12 [hp_X]/mL
BOS TAURUS PITUITARY GLAND, POSTERIOR — 12 [hp_X]/mL
THYROID, UNSPECIFIED — 12 [hp_X]/mL
BOS TAURUS HYPOTHALAMUS — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

29.57 mL in 1 BOTTLE, GLASS (58264-0145-1) · 58264-0145-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →